Cargando…
Single-dose baclofen-induced neurotoxicity in a patient with end stage renal disease: case report
BACKGROUND: Baclofen is a centrally acting GABA(B) receptor agonist and it is used widely for the treatment of spasticity, persistent hiccups and multiple sclerosis. The renal system is the main route of excretion, thus people with suboptimal renal function are prone to baclofen intoxication. Multip...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6288861/ https://www.ncbi.nlm.nih.gov/pubmed/30537935 http://dx.doi.org/10.1186/s12882-018-1167-z |
_version_ | 1783379872471580672 |
---|---|
author | Khazneh, Emad Shamlawi, Alaa Jebrin, Kamel Hamdan, Zakaria Sawalmeh, Osama |
author_facet | Khazneh, Emad Shamlawi, Alaa Jebrin, Kamel Hamdan, Zakaria Sawalmeh, Osama |
author_sort | Khazneh, Emad |
collection | PubMed |
description | BACKGROUND: Baclofen is a centrally acting GABA(B) receptor agonist and it is used widely for the treatment of spasticity, persistent hiccups and multiple sclerosis. The renal system is the main route of excretion, thus people with suboptimal renal function are prone to baclofen intoxication. Multiple doses of baclofen have been associated with toxicity, but it is very unusual that single dose can do so. CASE PRESENTATION: A 47 year old female patient with end stage renal disease (ESRD) presented with a sudden onset of altered mental status and state of unconsciousness after the ingestion of one tablet of baclofen 25 mg. All other possible causes were ruled out and a diagnosis of baclofen toxicity was considered. The patient showed dramatic improvement after an extra two sessions of hemodialysis. CONCLUSIONS: We highly recommend that more educational efforts are made for health care professionals about the possible risk of baclofen toxicity among kidney-impaired patients. We also recommend avoiding baclofen use if evidence of chronic renal disease is present and to seek other alternatives for pain management. |
format | Online Article Text |
id | pubmed-6288861 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-62888612018-12-14 Single-dose baclofen-induced neurotoxicity in a patient with end stage renal disease: case report Khazneh, Emad Shamlawi, Alaa Jebrin, Kamel Hamdan, Zakaria Sawalmeh, Osama BMC Nephrol Case Report BACKGROUND: Baclofen is a centrally acting GABA(B) receptor agonist and it is used widely for the treatment of spasticity, persistent hiccups and multiple sclerosis. The renal system is the main route of excretion, thus people with suboptimal renal function are prone to baclofen intoxication. Multiple doses of baclofen have been associated with toxicity, but it is very unusual that single dose can do so. CASE PRESENTATION: A 47 year old female patient with end stage renal disease (ESRD) presented with a sudden onset of altered mental status and state of unconsciousness after the ingestion of one tablet of baclofen 25 mg. All other possible causes were ruled out and a diagnosis of baclofen toxicity was considered. The patient showed dramatic improvement after an extra two sessions of hemodialysis. CONCLUSIONS: We highly recommend that more educational efforts are made for health care professionals about the possible risk of baclofen toxicity among kidney-impaired patients. We also recommend avoiding baclofen use if evidence of chronic renal disease is present and to seek other alternatives for pain management. BioMed Central 2018-12-11 /pmc/articles/PMC6288861/ /pubmed/30537935 http://dx.doi.org/10.1186/s12882-018-1167-z Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Case Report Khazneh, Emad Shamlawi, Alaa Jebrin, Kamel Hamdan, Zakaria Sawalmeh, Osama Single-dose baclofen-induced neurotoxicity in a patient with end stage renal disease: case report |
title | Single-dose baclofen-induced neurotoxicity in a patient with end stage renal disease: case report |
title_full | Single-dose baclofen-induced neurotoxicity in a patient with end stage renal disease: case report |
title_fullStr | Single-dose baclofen-induced neurotoxicity in a patient with end stage renal disease: case report |
title_full_unstemmed | Single-dose baclofen-induced neurotoxicity in a patient with end stage renal disease: case report |
title_short | Single-dose baclofen-induced neurotoxicity in a patient with end stage renal disease: case report |
title_sort | single-dose baclofen-induced neurotoxicity in a patient with end stage renal disease: case report |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6288861/ https://www.ncbi.nlm.nih.gov/pubmed/30537935 http://dx.doi.org/10.1186/s12882-018-1167-z |
work_keys_str_mv | AT khaznehemad singledosebaclofeninducedneurotoxicityinapatientwithendstagerenaldiseasecasereport AT shamlawialaa singledosebaclofeninducedneurotoxicityinapatientwithendstagerenaldiseasecasereport AT jebrinkamel singledosebaclofeninducedneurotoxicityinapatientwithendstagerenaldiseasecasereport AT hamdanzakaria singledosebaclofeninducedneurotoxicityinapatientwithendstagerenaldiseasecasereport AT sawalmehosama singledosebaclofeninducedneurotoxicityinapatientwithendstagerenaldiseasecasereport |